Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
9(90.0%)
Phase 2
1(10.0%)
10Total
N/A(9)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)